During the last session, Rallybio Corp (NASDAQ:RLYB)’s traded shares were 71509.0, with the beta value of the company hitting -1.23. At the end of the trading day, the stock’s price was $0.33, reflecting an intraday loss of -3.52% or -$0.01. The 52-week high for the RLYB share is $1.60, that puts it down -384.85 from that peak though still a striking 33.33% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $13.57M, and the average intraday trading volume over the past 10 days was 0.32 million shares, and the average trade volume was 179.99K shares over the past three months.
Rallybio Corp (RLYB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.50. RLYB has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
Rallybio Corp (NASDAQ:RLYB) trade information
Rallybio Corp (RLYB) registered a -3.52% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.52% in intraday trading to $0.33, hitting a weekly high. The stock’s 5-day price performance is -8.45%, and it has moved by -6.02% in 30 days. Based on these gigs, the overall price performance for the year is -78.89%. The short interest in Rallybio Corp (NASDAQ:RLYB) is 0.32 million shares and it means that shorts have 3.75 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -19.41%. While earnings are projected to return 8.08% in 2025, the next five years will return 11.24% per annum.
RLYB Dividends
Rallybio Corp is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Rallybio Corp (NASDAQ:RLYB)’s Major holders
Rallybio Corp insiders own 4.16% of total outstanding shares while institutional holders control 77.84%, with the float percentage being 81.22%. VIKING GLOBAL INVESTORS LP is the largest shareholder of the company, while 49.0 institutions own stock in it. As of 2024-06-30, the company held over 4.19 million shares (or 10.288% of all shares), a total value of $5.62 million in shares.
The next largest institutional holding, with 3.64 million shares, is of JOHNSON & JOHNSON’s that is approximately 8.9184% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $4.87 million.
